CAGE 057Y1Observed activity · FY2019–FY2024UEI CNPVCR8DK7M8

EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.

GAITHERSBURG, MD

Ultimate parent
EMERGENT BIOSOLUTIONS
UEI M7ZHZ4P2MDG4

EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. is a defense supplier facility identified by CAGE 057Y1 in GAITHERSBURG, MD. The contractor received $8.6M in prime obligations during FY2019–FY2024. No tracked subcontract awards were identified for that period. Observed award classifications include R&d- Medical: Other (advanced Development); R&d- Medical: Biomedical (applied Research/exploratory Development).

Observed prime obligations
$8.6M
Tracked subcontract value
$0

Connected platforms

Percentages show share of all observed prime obligation value.

No mapped platform relationships are shown.

Upstream prime customers

Percentages show share of all tracked subcontract award value received.

No tracked upstream prime customer is shown.

Government customers

Percentages show share of all observed prime obligation value.

Defense Health Agency79% of prime
Defense Threat Reduction Agency33.4% of prime

Subcontractors

Percentages show share of tracked subcontract awards issued.

No tracked downstream subcontractor is shown.

Observed capabilities

R&d- Medical: Other (advanced Development)R&d- Medical: Biomedical (applied Research/exploratory Development)

Connected NSNs

No observed NSNs are shown.

Largest observed award · base-award description

W81XWH19C0193 · $5.7M

CREATION OF AN FDA APPROVED ANALGESIC KETAMINE DRUG WITH AUTO INJECTOR DELIVERY SYSTEM.

Ask Mimir about EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.

Open Ask Mimir with this company and CAGE already in context.

Ask a question
Explore the full profile in Mimir

Continue to the wider platform for deeper contracts, suppliers, parts and analysis.

Open platform

Privacy at Mimir

We use first-party product analytics to improve Mimir. You can opt out or choose campaign measurement.